Skip to content

Detection and analysis of common biomarkers of chronic obstructive pulmonary disease

Detection and analysis of common biomarkers of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-13004113
Enrollment
Unknown
Registered
2013-10-12
Start date
2013-10-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The National Key Technology R&D Program 2012BAI05B01 (P.R.)

Interventions

Gold Standard:
Index test:

Sponsors

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged 40-80 years, both male and female, with or without smoking history; (2) GOLD Stage I-IV COPD: FEV1/FVC<70%, measured 20min after 400µg salbutamol inhalation; Healthy control: no respiratory disease diagnosis and other disease diagnosis,without antibiotics or no acute respiratory infection symptoms over the past four weeks; (3) With stable COPD: no COPD exacerbation during the latest 4 weeks prior to the recruitment; (4) With capability of communicating via oral conversation or written documents and signing informed consent and with agreement to receive and are capable of participating in study related auxiliary examinations.

Exclusion criteria

Exclusion criteria: (1) Received thoracic and abdominal operation and eye surgery in three months; (2) Severe cardiovascular, neural, hepatic, renal and hematologic diseases or malignancies that may interfere with the operation of the study; (3)Being treated with anti-tuberculosis drugs or active tuberculosis; (4) Mental illness: auditory hallucination, visual hallucination, taking antipsychotic drugs; (5) cognitive disorder: including dementia comprehension obstacles; (6) During pregnancy or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
biomarker;

Countries

China

Contacts

Public ContactPX. RAN

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases,First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

pxran@vip.163.com+86 13922765811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026